학술논문

RNA-binding proteins direct myogenic cell fate decisions.
Document Type
article
Source
Subject
Muscle
Skeletal
Animals
Mice
RNA-Binding Proteins
Cell Differentiation
Muscle Development
Muscle Fibers
Skeletal
RNA splicing
RNA-binding protein
mouse
post-transcriptional regulation
regeneration
regenerative medicine
skeletal muscle
splicing network
stem cells
Stem Cell Research - Nonembryonic - Non-Human
Genetics
Regenerative Medicine
Stem Cell Research
1.1 Normal biological development and functioning
Underpinning research
Musculoskeletal
Mouse
Biochemistry and Cell Biology
Language
Abstract
RNA-binding proteins (RBPs), essential for skeletal muscle regeneration, cause muscle degeneration and neuromuscular disease when mutated. Why mutations in these ubiquitously expressed RBPs orchestrate complex tissue regeneration and direct cell fate decisions in skeletal muscle remains poorly understood. Single-cell RNA-sequencing of regenerating Mus musculus skeletal muscle reveals that RBP expression, including the expression of many neuromuscular disease-associated RBPs, is temporally regulated in skeletal muscle stem cells and correlates with specific stages of myogenic differentiation. By combining machine learning with RBP engagement scoring, we discovered that the neuromuscular disease-associated RBP Hnrnpa2b1 is a differentiation-specifying regulator of myogenesis that controls myogenic cell fate transitions during terminal differentiation in mice. The timing of RBP expression specifies cell fate transitions by providing post-transcriptional regulation of messenger RNAs that coordinate stem cell fate decisions during tissue regeneration.